- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03741556
Prognostic Factors Following Ankle Fractures
Recovery Following Ankle Fracture Reported by Patient Report Outcome
Study Overview
Detailed Description
Aim of study:
To identify prognostic factors associated with a worse outcome following ankle fractures.
Method:
All operated or non-operated ankle fractures in a period of one year from three different hospitals will be included. The following data will be recorded:
Civil registration number, age, rupture of the syndesmosis, use of alcohol, smoking, diabetes, characteristics of the ankle fracture (AO classification), type of treatment and complications.
Study participants will at time of diagnosis and 6, 12, 52 and 104 weeks following the injury received a questionaire with Manchester foot and ankle questionnaire (MOXFQ), Self-reported foot and ankle questionnaire (SEFAS), Olerud Molander Ankle Score (OMAS) and Forgotten Joint Score (FJS).
Which of the questionaire that should be used in the study will be determined when the questionaires have been compared in a different study.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Copenhagen, Denmark, 2650
- Amager Hvidovre Hospital
-
Kolding, Denmark, 6000
- Sygehus Lillebaelt
-
Odense, Denmark, 5000
- Odense University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- All patients with ankle fracture.
Exclusion Criteria:
- age below 18 years
- patients who do not speak or understand danish
- mental disable patients
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Manchester foot and ankle questionnaire (MOXFQ)
Time Frame: 2 years
|
Manchester foot and ankle questionnaire (MOXFQ) a Patient reported outcome measure.
The MOXFQ contains 16 items, each with five response options, comprising three dimensions: walking/standing problems (seven items), foot pain (five items), and issues related to social interaction (four items), including feelings of self consciousness about foot/footwear appearance.
Responses are each scored from 0 to 4, with 4 representing the most severe response.
Item responses are summed to give a score from 0-100, with higher score representing the worse possible
|
2 years
|
|
Self-reported foot and ankle questionnaire (SEFAS)
Time Frame: 2 years
|
The Self-reported foot and ankle questionnaire (SEFAS) comprises twelve items relating to pain, limping, swelling, use of orthotics and walking.
Response scales vary from 1 to 5, 1 being the most severe response.
Item responses are summed to give a score from 12-60, with higher scores representing the best possible.
|
2 years
|
|
Olerud Molander Ankle Score (OMAS)
Time Frame: 2 years
|
The Olerud Molander Ankle Score (OMAS) comprises nine items relating to symptoms, physical function and daily activities.
The response scales vary from binary to five-points with clinical scoring that reflects the level of disability for individual items.
Item responses are summed to give a score from 0 to 100 with higher scores representing the best possible
|
2 years
|
|
Forgotten Joint Score (FJS)
Time Frame: 2 years
|
The forgotten Joint Score (FJS) is a 12-item questionnaire concerning the participiants awareness of their artificial joint during ADL.
For each question, the participant can choose between 6 response options: never, almost never, seldom, sometimes, mostly, or not relevant for me.
All responses are summed from 0-4 with a total score from 0-100 with higher scores representing the worse possible
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
EQ5D-3L
Time Frame: 2 years
|
The EQ5D-3L is a generic PROM and does not specifically address foot and ankle disability.
The EQ-5D-3L includes five items with a three-point response scale which are scored to give a single index, with 0 representing the worse possible disability.
It also includes a visual analoug scale (VAS) to assess general health, ranging from 0-100, with 0 representing the worse possible health state
|
2 years
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Ver2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ankle Fractures
-
The University of Texas Health Science Center,...AO Trauma North AmericaCompletedDisplaced Ankle FracturesUnited States
-
Hadassah Medical OrganizationCompleted
-
Shaikh Zayed Hospital, LahoreCompletedBimalleolar Ankle FracturePakistan
-
University of ArizonaActive, not recruitingUnstable Ankle Fractures With Syndesmotic DisruptionUnited States
-
Nova Scotia Health AuthorityBauerfeindNot yet recruitingAnkle Fracture | Ankle ArthrodesisCanada
-
Sohag UniversityRecruitingFragility Ankle Fractures and Complex Distal Tibial FracturesEgypt
-
Encore Medical, L.P.RecruitingBimalleolar Ankle FracturesUnited States
-
Utku GürhanNot yet recruitingAnkle Injuries | Ankle FracturesCyprus, Turkey (Türkiye)
-
Brian W. NoehrenRecruiting
-
Cairo UniversityCompleted
Clinical Trials on questionaire
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterFox Chase Cancer Center; University of ChicagoActive, not recruitingBladder Cancer | Urothelial Cancer | Ureter Cancer | Renal Pelvis CancerUnited States
-
Nordic Society of Gynaecological Oncology - Clinical...Australia New Zealand Gynaecological Oncology GroupRecruitingGynaecological CancerNorway
-
Cairo UniversityUnknownWork-Related Musculoskeletal Disorders Among EGYPTIAN OtorhinolarngologistsEgypt
-
Hongmei ZhangCompleted
-
Cairo UniversityNot yet recruitingPatients Attitude on AI in Dentistry | Trust AI | Concerns on AIEgypt
-
Western University, CanadaNot yet recruiting
-
Eurofertil IVF Health CenterCompletedStress | PregnancyTurkey
-
Zurich University of Applied SciencesCompleted
-
Aljazeera HospitalCairo UniversityUnknown